112,95 €
112,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
56 °P sammeln
112,95 €
112,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
56 °P sammeln
Als Download kaufen
112,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
56 °P sammeln
Jetzt verschenken
112,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
56 °P sammeln
  • Format: PDF

The only text available today which provides an up to date account of international pharmaceutical policy research. | Analyses the most relevant areas that may impact on the quality use of medicines and ultimately the health of populations. | Fills a significant gap in the literature by offering a comprehensive analysis of pharmaceutical policy from a global point of view. | Essential and timely resource for funders, policy makers, researchers and academics involved in research on pharmaceutical policy or involved in the teaching of pharmacy or medicine.

Produktbeschreibung
  • The only text available today which provides an up to date account of international pharmaceutical policy research.
  • Analyses the most relevant areas that may impact on the quality use of medicines and ultimately the health of populations.
  • Fills a significant gap in the literature by offering a comprehensive analysis of pharmaceutical policy from a global point of view.
  • Essential and timely resource for funders, policy makers, researchers and academics involved in research on pharmaceutical policy or involved in the teaching of pharmacy or medicine.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of the Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. He has an in-depth understanding of global health, pharmacy systems and pharmaceutical policy and has worked in Malaysia, New Zealand, Pakistan and the UK.